Physician profile
Them Le Vu
NPI 1003829334
$1,945.27
in general payments reported to CMS, 2019-2025
18 companies · $72.42 in 2025
The $72.42 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $181 · 2021: $345 · 2022: $664 · 2023: $190 · 2024: $270 · 2025: $72.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $882.11 | 2021-2025 | |
| Allergan, INC. | $330.84 | 2019-2022 | |
| Dompe US, INC. | $138.25 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $104.56 | 2021 | |
| Bausch & Lomb Americas INC. | $72.57 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Mallinckrodt Hospital Products INC. | $67.71 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $61.21 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $44.98 | 2021 | |
| Aerie Pharmaceuticals, INC. | $37.82 | 2021 | |
| Shire North American Group INC | $36.24 | 2019 | |
| Abbvie INC. | $32.41 | 2023 | Lumigan, Vuity, Alphagan P |
| Oyster Point Pharma, INC. | $26.83 | 2023 | Tyrvaya |
| Alcon Vision LLC | $23.55 | 2022 | |
| Glaukos Corporation | $21.86 | 2019 | |
| Kala Pharmaceuticals, INC. | $18.66 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $17.24 | 2023 | |
| Sight Sciences, INC. | $14.78 | 2019 | |
| Harrow Eye, LLC | $13.65 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Them Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.